TET2 and acute myeloid leukemia: In a cohort of CN-AML, multiple tumor suppressor TET2-targeting miRs, such as miR-29b/-29c and miR-125b, were preferentially overexpressed in TET2-wildtype samples than those with TET2-mutations (65).